Viewing Study NCT04368559


Ignite Creation Date: 2025-12-24 @ 2:23 PM
Ignite Modification Date: 2026-02-22 @ 4:14 PM
Study NCT ID: NCT04368559
Status: RECRUITING
Last Update Posted: 2025-07-29
First Post: 2020-04-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation
Sponsor: Mundipharma Research Limited
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Candidemia View
None Mycoses View
None Fungal Infection View
None Fungemia View
None Invasive Candidiasis View
None Pneumocystis View
None Mold Infection View
None Invasive Fungal Disease View
None Prophylaxis of Invasive Fungal Infections View
None Aspergillus View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Mycoses View
None Prophylaxis of Invasive Fungal Infections View
None Aspergillus View
None Candidiasis View
None Candidemia View
None Candidiasis, Invasive View
None Fungemia View
None Sepsis View
None Blood and Marrow Transplant (BMT) View
None Infection View
None Invasive Fungal Infections View
None Systemic Inflammatory Response Syndrome View
None Inflammation View
None Pathologic Processes View
None Fluconazole View
None Posaconazole View
None Caspofungin View
None Trimethoprim-sulfamethoxazole (TMP/SMX) View
None Echinocandins View
None Antifungal Agents View
None 14-alpha Demethylase Inhibitors View
None Cytochrome P-450 Enzyme Inhibitors View
None Enzyme Inhibitors View
None Molecular Mechanisms of Pharmacological Action View
None Steroid Synthesis Inhibitors View
None Physiological Effects of Drugs View
None Cytochrome P-450 CYP2C9 Inhibitors View
None Cytochrome P-450 CYP2C19 Inhibitors View
None Pneumocystis View
None Mold Infection View
None Rezafungin View
None Anti-Infective Agents View